Qualification
MBBS, DM (Oncology)Languages
English Hindi Kannada TeluguWork Experience
25 YearsResearch Experience
• FDG-PET Metabolic Vs CT Anatomical Monitoring of Tumour Response to Anterior Chemotherapy in Breast Carcinoma - The Uncertainties. Cancer Therapy & Oncol Int J. 2021; 19(1): 556003.• Landscape of clinically actionable mutations in breast cancer 'A cohort study'. Transl Oncol. 2021 Jan;14(1):100877.
• Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3-years follow-up study. J Oral Pathol Med. 2020 Sep;49(8):803-808.
• Circulating tumour cells in head and neck cancers: Biological insights. J Oral Pathol Med. 2020 Oct;49(9):842-848.
• Palbociclib in hormone-positive metastatic breast cancer: A real-world multicentre Indian experience.
• Journal of Clinical Oncology 38(15_suppl):e13057-e13057 (2020).
• Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study. Advances in Breast Cancer Research 09(04):110-118. (2020).
Awards & Achivements
Dr. Shekar Patil's exceptional contributions to the field of medical oncology have been recognized through numerous prestigious awards and honors:• Dr. B.C Roy award from the Indian Medical Association
Karnataka State Branch: A distinguished award bestowed upon exceptional physicians for their outstanding contributions to the medical profession.
• Lifetime Achievement Award from the Association of Radiation Oncologists of India (AROI): A pinnacle of recognition
honoring Dr. Patil's unwavering dedication and exceptional contributions to the field of radiation oncology.
Memberships
• Association of Radiation Oncologists of India (AROI)• Indian Society of Oncology (ISO)
• Karnataka Oncology Society (KOS)
Area of Interest
• Dr. Patil is well-experienced and his expertise expands to several areas like conventional & high-dose radiotherapy for solid and hematological malignanciesintraperitoneal chemotherapy for advanced ovarian cancer
concurrent radiation
and chemotherap